A Texas-sized verdict

22 Aug 2005 By Robert Cyran

The US drug company picked what looked an easy win for its first court defence of recalled painkiller Vioxx. It lost spectacularly. The verdict will be reduced. But the group s own goal may cost it billions.

This content is for Subscribers only

or
If you need assistance please email breakingviews.clientsupport@thomsonreuters.com
 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)

We need you to verify your email address to continue. Please check your email/junk folder for our verification request.

Click here to resend the verification email.